Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.527
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.587
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.572
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
35f:40m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.318
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.151
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.393
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000323
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0140
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.373
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.140
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0343
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
232f:387m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
232f:387m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.367
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.533
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.903
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.379
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.000934
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.411
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat/Body weight
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.143
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.620
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.196
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.746
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat mass
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.281
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Carbon dioxide production
|
HOM
|
882f:1008m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
5f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.583
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.412
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Oxygen consumption
|
HOM
|
882f:1008m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.977
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
882f:1008m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0484
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Dysmorphology / fat distribution
|
HOM
|
7f:8m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.955
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.316
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.422
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.528
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.700
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0734
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.165
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.640
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.177
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.754
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.906
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.728
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0595
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Total food intake
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0510
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.793
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.236
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0825
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0806
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00738
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0507
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.558
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.406
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.477
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.410
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.245
|
Successful |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
232f:387m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
1f:1m
|
|
|
NotProcessed |
Slc35f6tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0416
|
Successful |